Baird Financial Group, Inc. - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 104 filers reported holding ARATANA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$233,000
-16.2%
44,344
-2.3%
0.00%0.0%
Q3 2017$278,000
-13.4%
45,400
+2.2%
0.00%
-33.3%
Q2 2017$321,000
+48.6%
44,413
+9.0%
0.00%
+50.0%
Q1 2017$216,000
-2.7%
40,758
+32.0%
0.00%0.0%
Q4 2016$222,000
-18.7%
30,878
+5.7%
0.00%0.0%
Q3 2016$273,000
+37.9%
29,219
+0.1%
0.00%0.0%
Q2 2016$198,00029,2010.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
March Altus Capital Management LP 218,515$1,219,00011.21%
Broadfin Capital, LLC 3,428,865$19,133,0001.18%
MPM ASSET MANAGEMENT LLC 1,117,875$6,238,0001.11%
AlpInvest Partners B.V. 100,001$558,0000.93%
First Light Asset Management, LLC 395,043$2,204,0000.92%
Westend Capital Management, LLC 89,780$501,0000.69%
Grandeur Peak Global Advisors, LLC 460,675$2,571,0000.53%
AWM Investment Company, Inc. 467,507$2,609,0000.51%
HAMILTON LANE ADVISORS LLC 111,705$623,0000.27%
Sio Capital Management, LLC 97,376$543,0000.24%
View complete list of ARATANA THERAPEUTICS INC shareholders